Back

Immune-epicardial adiposity, associated with coronary artery disease, is modulated by semaglutide

30 August 2026 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms of arrhythmias and gender differences Coronary Artery Disease ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Jose Ramon Gonzalez Juanatey

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

7 More presentations in this session

Presentation thumbnail
Mexiletine in drug-refractory ventricular arrhythmias: real-world effectiveness and tolerability
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Accelerated biological aging increases the 10-year mortality risk in patients with coronary artery disease after percutaneous coronary intervention
Doctor M. Liu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Mortality and device intervention in patients with a history of atrial fibrillation: a substudy of APPRAISE ATP
Professor G. Boriani (Modena, IT)
Abstract Slides Video
Presentation thumbnail
Sex differences in long-term arrhythmogenic and mortality outcomes in patients with hypertrophic cardiomyopathy: a 20-year longitudinal observational study
Doctor D. Silva (Rochester, US)
Abstract Slides Video
Presentation thumbnail
From systemic adiposity to local epicardial adipose tissue targets: uncovering novel mechanisms and biomarkers in atrial fibrillation
Mr S. Huang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Mechanisms of arrhythmias and gender differences

The Event

Event poster

ESC Congress 2026

30 August 2026 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.
30 August 2024
thumbnail
Congress Presentation
Cardiovascular magnetic resonance tissue characterization of epicardial adipose tissue in acute STEMI: association with myocardial injury and systemic inflammation – exploratory pilot study
30 August 2026
thumbnail
Congress Presentation
Cellular deep proteomic profiling elucidates NLRP3 inflammasome and immunothrombosis effects of GLP-1 receptor agonist: a controlled intervention study
28 August 2026
thumbnail
Congress Presentation
Real-world impact of oral semaglutide on inflammatory markers in patients at high cardiovascular risk
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources